Heart failure & cardiomyopathiesCross-sectional study
Iron Deficiency and Supplementation in Patients with Heart Failure: Results from the IRON-HF International Survey
- Cross-sectional study
- online survey (23 questions)
- international
Study context
- Population
- Cardiologists managing patients with heart failure (HF)
- Participants
- 256 cardiologists
Main finding
As reported in the abstract
Real-world practices in ID screening and management in HF
- Defined iron deficiency (ID) per most recent HF recommendations
- 98.4%
- Screened for ID in more than half of their patients
- 68.4%
- Performed periodic screening (every 6 months to 1 year)
- 54.3%
- Prescribed and/or administered iron supplementation
- 93.0%
- IV iron as preferred administration
- 86.3%
- Reassessed ID after iron supplementation
- 96.1%
- Reassessment most frequently at 3-6 months
- 67.6%
- Perceived ID as an underestimated comorbidity in HF
- 93.8%
Observational data: associations, not effects.
Original publication
Iron Deficiency and Supplementation in Patients with Heart Failure: Results from the IRON-HF International Survey. Eur J Heart Fail. Published 4 July 2024. doi:10.1002/ejhf.3356
Summarised from the published abstract; every number is checked against it